NYSE:TEVAPharmaceuticals
Is It Too Late To Reassess Teva (TEVA) After Its 118.5% One-Year Surge?
If you are wondering whether Teva Pharmaceutical Industries at about US$31.22 is still reasonably priced after its strong run, the next sections walk through what the current market price may be implying.
The stock has returned 8.5% over the last 30 days and 118.5% over the last year, while year to date the move sits at 0.9% and the 7 day return is a 1.2% decline.
Recent news flow around Teva has focused on its position in the broader pharmaceuticals sector and ongoing investor interest in...